Grifols S.A.

Jul 09, 2020

Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe

Apr 06, 2020

Grifols 2019 Annual Report on Form 20-F Filed With the SEC on April 6, 2020

Mar 25, 2020

Grifols Announces Formal Collaboration with US Government to Produce the First Treatment Specifically Targeting COVID-19

Dec 06, 2019

Grifols presents its latest Alzheimer's clinical trial data

Dec 02, 2019

Grifols to present latest Alzheimer's clinical trial results

Jul 16, 2019

Grifols presents additional encouraging Alzheimer's trial results at AAIC

Jul 04, 2019

Grifols Announces FDA Approval of Xembify®, 20% Subcutaneous Immunoglobulin for Primary Immunodeficiencies

Apr 05, 2019

Grifols 2018 Annual Report on Form 20-F Filed With the SEC on April 5, 2019

Oct 27, 2018

Grifols demonstrates a significant reduction (61%) in the progression of moderate Alzheimer's disease using its AMBAR treatment protocol

Apr 16, 2018

Grifols donates over 25 million international units of blood clotting factor in 2017

Apr 06, 2018

Grifols 2017 Annual Report on Form 20-F filed with the SEC on April 6, 2018

Jun 16, 2017

Daily Technical Summary Reports on Biotech Stocks -- Illumina, Navidea Biopharma, Grifols, and Intercept Pharma